19
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Stage I and II Hodgkin's Disease with NOVP (Mitoxantrone, Vincristine, Vinblastine, Prednisone) and Radiotherapy

, , , , &
Pages 137-142 | Accepted 01 Sep 1998, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mariano Provencio, Pilar España, Isabel Millán, Antonio Sánchez, Blanca Cantos & Félix Bonilla. (2003) The Management of Stage I-II Supradiaphragmatic Hodgkin's Disease with Chemotherapy Alone. Leukemia & Lymphoma 44:2, pages 263-268.
Read now

Articles from other publishers (6)

Andrea K. Ng, Lawrence M. Weiss & Ann S. LaCasce. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology 1506 1523.e5 .
Andrea K. Ng, Lawrence Weiss & Ann S. LaCasce. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology 1527 1543 .
. 2006. The Lymphomas. The Lymphomas 476 499 .
Gregory M. Chronowski, Richard B. Wilder, Larry B. Levy, Edward N. Atkinson, Chul S. Ha, Fredrick B. Hagemeister, Ibrahim Barista, Maria A. Rodriguez, Andreas H. Sarris, Mark A. Hess, Fernando Cabanillas & James D. Cox. (2004) Second Malignancies After Chemotherapy and Radiotherapy for Hodgkin Disease. American Journal of Clinical Oncology 27:1, pages 73-80.
Crossref
Gregory M Chronowski, Richard B Wilder, Susan L Tucker, Chul S Ha, Anas Younes, Luis Fayad, Maria A Rodriguez, Fredrick B Hagemeister, Ibrahim Barista, Fernando Cabanillas & James D Cox. (2003) Analysis of in-field control and late toxicity for adults with early-stage hodgkin’s disease treated with chemotherapy followed by radiotherapy. International Journal of Radiation Oncology*Biology*Physics 55:1, pages 36-43.
Crossref
Gregory M. Chronowski, Richard B. Wilder, Susan L. Tucker, Chul S. Ha, Andreas H. Sarris, Fredrick B. Hagemeister, Ibrahim Barista, Mark A. Hess, Fernando Cabanillas & James D. Cox. (2002) An elevated serum beta‐2‐microglobulin level is an adverse prognostic factor for overall survival in patients with early‐stage Hodgkin disease. Cancer 95:12, pages 2534-2538.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.